101 related articles for article (PubMed ID: 26039550)
21. A Comparison of Two Sensory Panels Trained with Different Feedback Calibration Range Specifications via Sensory Description of Five Beers.
Elgaard L; Mielby LA; Hopfer H; Byrne DV
Foods; 2019 Nov; 8(11):. PubMed ID: 31683760
[TBL] [Abstract][Full Text] [Related]
22. Computational multiplex panel reduction to maximize information retention in breast cancer tissue microarrays.
Ternes L; Lin JR; Chen YA; Gray JW; Chang YH
PLoS Comput Biol; 2022 Sep; 18(9):e1010505. PubMed ID: 36178966
[TBL] [Abstract][Full Text] [Related]
23. Developmental validation of a custom-designed Multi-InDel panel: A five-dye multiplex amplification system for challenging DNA samples.
Electrophoresis; 2024 Mar; 45(5-6):573-577. PubMed ID: 38500305
[No Abstract] [Full Text] [Related]
24. Evaluation of Hybridization Capture Versus Amplicon-Based Methods for Whole-Exome Sequencing.
Samorodnitsky E; Jewell BM; Hagopian R; Miya J; Wing MR; Lyon E; Damodaran S; Bhatt D; Reeser JW; Datta J; Roychowdhury S
Hum Mutat; 2015 Sep; 36(9):903-14. PubMed ID: 26110913
[TBL] [Abstract][Full Text] [Related]
25. Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers.
Haley L; Tseng LH; Zheng G; Dudley J; Anderson DA; Azad NS; Gocke CD; Eshleman JR; Lin MT
Mod Pathol; 2015 Oct; 28(10):1390-9. PubMed ID: 26226847
[TBL] [Abstract][Full Text] [Related]
26. Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Elderly Patients With Breast Cancer.
Nikolaidi A; Kotoula V; Koliou GA; Giannoulatou E; Papadopoulou K; Zagouri F; Pentheroudakis G; Gogas H; Bobos M; Chatzopoulos K; Oikonomopoulos G; Pectasides D; Saloustros E; Arnogiannaki N; Nicolaou I; Papakostas P; Bompolaki I; Aravantinos G; Athanasiadis I; Fountzilas G
Cancer Genomics Proteomics; 2020; 17(2):181-193. PubMed ID: 32108041
[TBL] [Abstract][Full Text] [Related]
27. Opposite Prognostic Impact of Single PTEN-loss and
Lazaridis G; Kotoula V; Vrettou E; Kostopoulos I; Manousou K; Papadopoulou K; Giannoulatou E; Bobos M; Sotiropoulou M; Pentheroudakis G; Efstratiou I; Papoudou-Bai A; Psyrri A; Christodoulou C; Gogas H; Koutras A; Timotheadou E; Pectasides D; Zagouri F; Fountzilas G
Cancer Genomics Proteomics; 2019; 16(3):195-206. PubMed ID: 31018950
[TBL] [Abstract][Full Text] [Related]
28. Biotinylated amplicon sequencing: A method for preserving DNA samples of limited quantity.
Cravero K; Medford A; Pallavajjala A; Canzoniero J; Hunter N; Chu D; Cochran RL; Waters I; Christenson ES; Kyker-Snowman K; Button B; Cole AJ; Park BH
Pract Lab Med; 2018 Nov; 12():e00108. PubMed ID: 30140723
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.
Levva S; Kotoula V; Kostopoulos I; Manousou K; Papadimitriou C; Papadopoulou K; Lakis S; Koukoulias K; Karavasilis V; Pentheroudakis G; Balassi E; Zagouri F; Kaklamanos IG; Pectasides D; Razis E; Aravantinos G; Papakostas P; Bafaloukos D; Rallis G; Gogas H; Fountzilas G
Cancer Genomics Proteomics; 2017; 14(3):181-195. PubMed ID: 28446533
[TBL] [Abstract][Full Text] [Related]
30. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
Kamps R; Brandão RD; Bosch BJ; Paulussen AD; Xanthoulea S; Blok MJ; Romano A
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146134
[TBL] [Abstract][Full Text] [Related]
31. The fate of BRCA1-related germline mutations in triple-negative breast tumors.
Kotoula V; Fostira F; Papadopoulou K; Apostolou P; Tsolaki E; Lazaridis G; Manoussou K; Zagouri F; Pectasides D; Vlachos I; Tikas I; Lakis S; Konstantopoulou I; Pentheroudakis G; Gogas H; Papakostas P; Christodoulou C; Bafaloukos D; Razis E; Karavasilis V; Bamias C; Yannoukakos D; Fountzilas G
Am J Cancer Res; 2017; 7(1):98-114. PubMed ID: 28123851
[TBL] [Abstract][Full Text] [Related]
32. Disease evolution and heterogeneity in bilateral breast cancer.
Fountzilas E; Kotoula V; Zagouri F; Giannoulatou E; Kouvatseas G; Pentheroudakis G; Koletsa T; Bobos M; Papadopoulou K; Samantas E; Demiri E; Miliaras S; Christodoulou C; Chrisafi S; Razis E; Fostira F; Pectasides D; Zografos G; Fountzilas G
Am J Cancer Res; 2016; 6(11):2611-2630. PubMed ID: 27904775
[TBL] [Abstract][Full Text] [Related]
33. Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.
Kotoula V; Lakis S; Vlachos IS; Giannoulatou E; Zagouri F; Alexopoulou Z; Gogas H; Pectasides D; Aravantinos G; Efstratiou I; Pentheroudakis G; Papadopoulou K; Chatzopoulos K; Papakostas P; Sotiropoulou M; Nicolaou I; Razis E; Psyrri A; Kosmidis P; Papadimitriou C; Fountzilas G
PLoS One; 2016; 11(9):e0163138. PubMed ID: 27685159
[TBL] [Abstract][Full Text] [Related]
34. TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.
Fountzilas G; Giannoulatou E; Alexopoulou Z; Zagouri F; Timotheadou E; Papadopoulou K; Lakis S; Bobos M; Poulios C; Sotiropoulou M; Lyberopoulou A; Gogas H; Pentheroudakis G; Pectasides D; Koutras A; Christodoulou C; Papandreou C; Samantas E; Papakostas P; Kosmidis P; Bafaloukos D; Karanikiotis C; Dimopoulos MA; Kotoula V
Oncotarget; 2016 May; 7(22):32731-53. PubMed ID: 27129168
[TBL] [Abstract][Full Text] [Related]
35. Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.
Papaxoinis G; Kotoula V; Alexopoulou Z; Kalogeras KT; Zagouri F; Timotheadou E; Gogas H; Pentheroudakis G; Christodoulou C; Koutras A; Bafaloukos D; Aravantinos G; Papakostas P; Charalambous E; Papadopoulou K; Varthalitis I; Efstratiou I; Zaramboukas T; Patsea H; Scopa CD; Skondra M; Kosmidis P; Pectasides D; Fountzilas G
PLoS One; 2015; 10(10):e0140293. PubMed ID: 26452060
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNA.
Kotoula V; Lyberopoulou A; Papadopoulou K; Charalambous E; Alexopoulou Z; Gakou C; Lakis S; Tsolaki E; Lilakos K; Fountzilas G
PLoS One; 2015; 10(6):e0128818. PubMed ID: 26039550
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples.
Bhagwate AV; Liu Y; Winham SJ; McDonough SJ; Stallings-Mann ML; Heinzen EP; Davila JI; Vierkant RA; Hoskin TL; Frost M; Carter JM; Radisky DC; Cunningham JM; Degnim AC; Wang C
BMC Genomics; 2019 Sep; 20(1):689. PubMed ID: 31477010
[TBL] [Abstract][Full Text] [Related]
38. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
[TBL] [Abstract][Full Text] [Related]
39. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
Bonfiglio S; Vanni I; Rossella V; Truini A; Lazarevic D; Dal Bello MG; Alama A; Mora M; Rijavec E; Genova C; Cittaro D; Grossi F; Coco S
BMC Cancer; 2016 Aug; 16(1):692. PubMed ID: 27578032
[TBL] [Abstract][Full Text] [Related]
40. What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies.
Guillermin Y; Lopez J; Chabane K; Hayette S; Bardel C; Salles G; Sujobert P; Huet S
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29677173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
